ABSTRACT
Is observed a structure of five factors: representations, habitus, fields, capital, capabilities and enterprise that explained 54% of the total variance explained, although the research design limited findings local scenario, suggesting the inclusion of variables that the literature identifies Sociodemographic and socioeconomic variables to establish entrepreneurial profiles according to risk events;landslides, fires, droughts, floods, frosts or earthquakes. If a representation links coffee farming with other personal or community needs, then it supposes provisions that facilitate the objectification or anchoring of information related to sowing, harvesting, weather, pests, prices and prices. Faced with the environmental problems of droughts or floods, social capital networks in Xilitla respond with organization of the crop in diversified stages but confined to the achievement of goals that guarantee the productive cycle. The representations are discursive innovations from which scientific knowledge is disseminated in common sense and social thought, although this is exclusive of not only science, art or culture in general since the symbols to discover or invent are also prone to its transformation into interpretations of reality and more primarily discursive senses.
ABSTRACT
Received: 06-Feb-2023, Manuscript No. iphsj-23-13598;Editor assigned: 09-Feb-2023, Pre-QC No. iphsj-23-13598 (PQ);Reviewed: 30-Mar-2023, QC No. iphsj-23-13598;Revised: 04Apr-2023, Manuscript No. iphsj-23-13598 (R);Published: 11-Apr-2023, DOI: 10.36648/1791809X.17.4.1012 Introduction Until November 2022, the pandemic has claimed the lives of five million, although international health systems such as the World Health Organization and the Pan American Health Organization recognize the underreporting of community transmission. [...]the mitigation and containment policies of the pandemic through the implementation of distancing, confinement and immunization strategies limit the workplace and reorient it towards biosafety guidelines [9] In this situation, the theory of prospective decisions explains the relationships between leaders and talents in the face of contingent events [10] The theoretical approach raises differences between those who make decisions and those who abide by them [11]. Risks are also the result of their determinants, as is the case with the perception of control The emergence of self-control is the product of a high expectation of risk, but also of experiences of control that guide the individual to assume self-efficacy in health care. [...]the modeling of perception or expectation biases in the face of a risk such as infection, disease or death from COVID-19 has not been clarified.
ABSTRACT
INTRODUCTION AND OBJECTIVES: The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak. METHODS: Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19. RESULTS: Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P < .001) but showed no differences in the time from first medical contact to reperfusion. In-hospital mortality was higher during COVID-19 (7.5% vs 5.1%; unadjusted OR, 1.50; 95%CI, 1.07-2.11; P < .001); this association remained after adjustment for confounders (risk-adjusted OR, 1.88; 95%CI, 1.12-3.14; P = .017). In the 2020 cohort, there was a 6.3% incidence of confirmed SARS-CoV-2 infection during hospitalization. CONCLUSIONS: The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase in the rate of in-hospital mortality. No changes in reperfusion strategy were detected, with primary percutaneous coronary intervention performed for the vast majority of patients. The co-existence of STEMI and SARS-CoV-2 infection was relatively infrequent.
ABSTRACT
INTRODUCTION AND OBJECTIVES: The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak. METHODS: Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19. RESULTS: Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P<.001) but showed no differences in the time from first medical contact to reperfusion. In-hospital mortality was higher during COVID-19 (7.5% vs 5.1%; unadjusted OR, 1.50; 95%CI, 1.07-2.11; P <.001); this association remained after adjustment for confounders (risk-adjusted OR, 1.88; 95%CI, 1.12-3.14; P=.017). In the 2020 cohort, there was a 6.3% incidence of confirmed SARS-CoV-2 infection during hospitalization. CONCLUSIONS: The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase in the rate of in-hospital mortality. No changes in reperfusion strategy were detected, with primary percutaneous coronary intervention performed for the vast majority of patients. The co-existence of STEMI and SARS-CoV-2 infection was relatively infrequent.